Bill
Bill > HB1533
MD HB1533
MD HB1533Public Health - Cosmetic Products - Enforcement and Penalties for Prohibited Ingredients (Crown and Care Act - Protecting Communities from Harmful Hair Chemicals)
summary
Introduced
02/13/2026
02/13/2026
In Committee
04/10/2026
04/10/2026
Crossed Over
03/23/2026
03/23/2026
Passed
04/28/2026
04/28/2026
Dead
Signed/Enacted/Adopted
04/28/2026
04/28/2026
Introduced Session
2026 Regular Session
Bill Summary
Making a violation of certain provisions of law regarding the manufacture, sale, delivery, holding, or offering for sale certain cosmetic products an unfair, abusive, or deceptive trade practice; providing that a person who violates the Act is liable for certain civil damages resulting from actual harm sustained by an individual; requiring the Department of Health and the Attorney General to develop a plan for a fund to support research and treatment of conditions caused by harmful chemicals in cosmetic products; etc.
AI Summary
This bill, known as the Crown and Care Act, aims to protect communities from harmful hair chemicals by making it an unfair, abusive, or deceptive trade practice to knowingly manufacture, sell, deliver, hold, or offer for sale cosmetic products containing specific intentionally added ingredients, including certain phthalates, formaldehyde, lead, and per- and polyfluoroalkyl substances (PFAS). A "cosmetic" is defined as any substance intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance, excluding soap. Violators of these provisions are liable for civil damages resulting from actual harm sustained by an individual, with a three-year statute of limitations for bringing such actions after the injury is discovered or should have been discovered. The bill also allows for treble damages, punitive damages if the violation was willful, and reasonable attorney's fees to a prevailing plaintiff. Furthermore, the Maryland Department of Health and the Attorney General are required to develop a plan for a special fund to support research and treatment for conditions like fibroids, uterine cancer, and hair loss that may be caused by these harmful chemicals, with the fund to be comprised of certain funds recovered by the Attorney General's office and interest earnings. The Department of Health is also granted the authority to investigate complaints and inspect premises for compliance.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (24)
Tiffany Alston (D)*,
Nick Allen (D),
Heather Bagnall (D),
Regina Boyce (D),
Derrick Coley (D),
Bonnie Cullison (D),
Diana Fennell (D),
April Fleming Miller (R),
Pamela Guzzone (D),
Terri Hill (D),
Kevin Hornberger (R),
Aaron Kaufman (D),
Robbyn Lewis (D),
Lesley Lopez (D),
Ashanti Martínez (D),
Julie Palakovich Carr (D),
Kent Roberson (D),
Denise Roberts (D),
Sandy Rosenberg (D),
Kim Ross (D),
Emily Shetty (D),
Dana Stein (D),
Jennifer White Holland (D),
Teresa Woorman (D),
Last Action
Approved by the Governor - Chapter 284 (on 04/28/2026)
Bill Topics
Banking, Finance, and Domestic Commerce
- ‐ Consumer Safety and Consumer Fraud
Health
- ‐ Research and Development
- ‐ Treatment of Specific Diseases
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1533?ys=2026RS | 02/13/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/Chapters_noln/CH_284_hb1533e.pdf | 05/05/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/hb/hb1533e.pdf | 04/14/2026 |
| Favorable with Amendments 633321/1 Adopted | https://mgaleg.maryland.gov/2026RS/amds/bil_0003/hb1533_63332101.pdf | 04/10/2026 |
| Vote Image | https://mgaleg.maryland.gov/2026RS/votes_comm/hb1533_fin.pdf | 04/10/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/hb/hb1533t.pdf | 03/23/2026 |
| Favorable with Amendments 203123/1 Adopted | https://mgaleg.maryland.gov/2026RS/amds/bil_0003/hb1533_20312301.pdf | 03/23/2026 |
| Vote Image | https://mgaleg.maryland.gov/2026RS/votes_comm/hb1533_hlt.pdf | 03/21/2026 |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/hb/hb1533f.pdf | 02/14/2026 |
Loading...